| Faecalibacterium prausnitzii and human intestinal health S Miquel, R Martin, O Rossi, LG Bermúdez-Humarán, JM Chatel, H Sokol, ... Current opinion in microbiology 16 (3), 255-261, 2013 | 1076 | 2013 |
| Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria JG LeBlanc, F Chain, R Martín, LG Bermúdez-Humarán, S Courau, ... Microbial cell factories 16, 1-10, 2017 | 797 | 2017 |
| Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome JM Natividad, A Agus, J Planchais, B Lamas, AC Jarry, R Martin, ... Cell metabolism 28 (5), 737-749. e4, 2018 | 438 | 2018 |
| Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next … R Martín, S Miquel, L Benevides, C Bridonneau, V Robert, S Hudault, ... Frontiers in microbiology 8, 1226, 2017 | 358 | 2017 |
| Assessing the fecal microbiota: an optimized ion torrent 16S rRNA gene-based analysis protocol C Milani, A Hevia, E Foroni, S Duranti, F Turroni, GA Lugli, B Sanchez, ... PloS one 8 (7), e68739, 2013 | 322 | 2013 |
| Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease R Martín, S Miquel, J Ulmer, N Kechaou, P Langella, ... Microbial cell factories 12, 1-11, 2013 | 280 | 2013 |
| The Commensal Bacterium Faecalibacterium prausnitzii Is Protective in DNBS-induced Chronic Moderate and Severe Colitis Models R Martín, F Chain, S Miquel, J Lu, JJ Gratadoux, H Sokol, EF Verdu, ... Inflammatory bowel diseases 20 (3), 417-430, 2014 | 271 | 2014 |
| Emerging health concepts in the probiotics field: streamlining the definitions R Martín, P Langella Frontiers in microbiology 10, 457799, 2019 | 257 | 2019 |
| Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model R Martín, S Miquel, F Chain, JM Natividad, J Jury, J Lu, H Sokol, ... BMC microbiology 15, 1-12, 2015 | 252 | 2015 |
| Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii S Miquel, M Leclerc, R Martin, F Chain, M Lenoir, S Raguideau, S Hudault, ... MBio 6 (2), 10.1128/mbio. 00300-15, 2015 | 252 | 2015 |
| Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier … L Laval, R Martin, JN Natividad, F Chain, S Miquel, CD De Maredsous, ... Gut microbes 6 (1), 1-9, 2015 | 169 | 2015 |
| Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii. S Miquel, R Martín, C Bridonneau, V Robert, H Sokol, ... Gut Microbes 5 (2), 146-51, 2014 | 158 | 2014 |
| Characterization of indigenous vaginal lactobacilli from healthy women as probiotic candidates R Martín Rosique, NE Soberón Maltos, M Vaneechoutte, AB Flórez García, ... International Microbiology, 2008 | 157 | 2008 |
| Biosynthesis and Degradation of H2O2 by Vaginal Lactobacilli R Martín, JE Suárez Applied and environmental microbiology 76 (2), 400-405, 2010 | 149 | 2010 |
| The potential probiotic Lactobacillus rhamnosus CNCM I-3690 strain protects the intestinal barrier by stimulating both mucus production and cytoprotective response R Martín, C Chamignon, N Mhedbi-Hajri, F Chain, M Derrien, ... Scientific reports 9 (1), 5398, 2019 | 132 | 2019 |
| The role of metagenomics in understanding the human microbiome in health and disease R Martín, S Miquel, P Langella, LG Bermúdez-Humarán Virulence 5 (3), 413-423, 2014 | 129 | 2014 |
| Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3 M Lenoir, R Martín, E Torres-Maravilla, S Chadi, P González-Dávila, ... Gut Microbes 12 (1), 1826748, 2020 | 114 | 2020 |
| NSAID enteropathy and bacteria: a complicated relationship SD Syer, RW Blackler, R Martin, G de Palma, L Rossi, E Verdu, P Bercik, ... Journal of gastroenterology 50, 387-393, 2015 | 109 | 2015 |
| Development of a Stress-Inducible Controlled Expression (SICE) system in Lactococcus lactis for the production and delivery of therapeutic molecules at mucosal surfaces B Benbouziane, P Ribelles, C Aubry, R Martin, P Kharrat, A Riazi, ... Journal of biotechnology 168 (2), 120-129, 2013 | 108 | 2013 |
| La microbiota vaginal: composición, papel protector, patología asociada y perspectivas terapéuticas R Martín, N Soberón, F Vázquez, JE Suárez Enfermedades Infecciosas y Microbiología Clínica 26 (3), 160-167, 2008 | 100 | 2008 |
